Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
Leishmaniasis is affirmed as a category one disease (most emerging and unmanageable) by the World Health Organization (WHO), affecting 98 countries with an annual global incidence of ~1.2 million cases. Options for chemotherapeutic treatment are limited due to drug resistance and cytotoxicity. Thus,...
Saved in:
Main Authors: | Sayyed Ibrahim Shah (Author), Fazli Nasir (Author), Nadia Shamshad Malik (Author), Muhammad Alamzeb (Author), Muhammad Abbas (Author), Inayat Ur Rehman (Author), Fazli Khuda (Author), Yasir Shah (Author), Khang Weh Goh (Author), Alam Zeb (Author), Long Chiau Ming (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i><sub>NDM</sub>, <i>bla</i><sub>KPC</sub>, and ESBL-Producing Enterobacteriales Uropathogens
by: Lubna Razaq, et al.
Published: (2023) -
Estimation of dihydroartemisinin in human plasma using a highly sensitive LTQ Orbitrap mass spectrometer with Xcalibur software
by: Tareq Abu-Izneid, et al.
Published: (2023) -
Association of <i>bla</i><sub>VIM-2</sub>, <i>bla</i><sub>PDC-35</sub>, <i>bla</i><sub>OXA-10,</sub> <i>bla</i><sub>OXA-488</sub> and <i>bla</i><sub>VEB-9</sub> β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
by: Mazen A. Sid Ahmed, et al.
Published: (2022) -
<i>Pseudomonas aeruginosa</i> Coharboring <i>Bla</i><sub>KPC-2</sub> and <i>Bla</i><sub>VIM-2</sub> Carbapenemase Genes
by: Tatiana Pacheco, et al.
Published: (2019) -
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of Malaria
by: Annie Mayence, et al.
Published: (2019)